NEW YORK (GenomeWeb) – A team of Swedish researchers has received SEK 30 million ($3.3 million) to develop a new nanotechnology platform for detecting blood-borne markers in lung and breast cancer.

The Royal Institute of Technology (KTH) is leading the new project which is set to commence in January 2017. Researchers from Karolinska Institutet, SciLifeLab, and Acreo Swedish ICT, an electronics research institute based in Stockholm, are also taking part in the effort, which is being primarily funded via the Erling-Persson Family Foundation.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.